Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

BACKGROUND: Neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease with dementia (PDD), and dementia with Lewy bodies (DLB) share clinical and molecular features. Cerebrospinal fluid (CSF) biomarkers may help the characterization of these diseases, improving the differenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiasserini, Davide, Biscetti, Leonardo, Eusebi, Paolo, Salvadori, Nicola, Frattini, Giulia, Simoni, Simone, De Roeck, Naomi, Tambasco, Nicola, Stoops, Erik, Vanderstichele, Hugo, Engelborghs, Sebastiaan, Mollenhauer, Brit, Calabresi, Paolo, Parnetti, Lucilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532764/
https://www.ncbi.nlm.nih.gov/pubmed/28750675
http://dx.doi.org/10.1186/s13195-017-0276-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532764/
https://www.ncbi.nlm.nih.gov/pubmed/28750675
http://dx.doi.org/10.1186/s13195-017-0276-4

Ejemplares similares